PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Destiny Pharma’s novel antibiotic asset clears safety review

Brighton, UK-based Destiny Pharma has announced a positive interim safety review of its ongoing Phase IIb study of its lead antibiotic asset XF-73. Destiny Pharma ...
Continue Reading →
News

Bayer expands women’s health pipeline with KaNDy acquisition

Bayer has announced plans to acquire UK-based biotech company KaNDy Therapeutics, in a move to expand its drug development pipeline in women’s healthcare. This inc...
Continue Reading →
News

Gilead aims for approval of COVID-19 drug remdesivir in the US

Gilead is seeking full approval for its investigational COVID-19 drug remdesivir in the US, after filing an application with the US Food and Drug Administration (FDA...
Continue Reading →
News

Demand for mental health services to rise due to COVID-19, report finds

A report from the NHS Confederation has forecast that the peak in demand for mental healthcare in England is yet to come as the effects of the coronavirus pandemic c...
Continue Reading →
News

BMS’ Opdivo improves survival in gastric and oesophageal cancers

Bristol Myers Squibb has revealed the results from the Phase III CheckMate-649 evaluating Opdivo (nivolumab) plus chemotherapy in first-line metastatic gastric cance...
Continue Reading →
News

PharmaLex strengthens its commercial organization

The appointment of Sébastien Schmitt will further consolidatePharmaLex’s commercial offerings for our clients. PharmaLex Group, a leading provider of specialized s...
Continue Reading →
News

UK firm starts research on skin patch for COVID vaccines

Innoture has received funding from the Welsh Government to start proof-of-concept research into the use of its next-generation microneedle skin patch for the self-ad...
Continue Reading →
News

Janssen’s depression nasal spray Spravato bags new FDA approval

Janssen has received US Food and Drug Administration (FDA) approval for its Spravato  (esketamine) CIII nasal spray, in combination with an oral antidepres...
Continue Reading →
News

NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments

NHS chief executive Sir Simon Stevens has announced plans for a £160m initiative to roll-out ‘COVID-friendly’ cancer treatments for patients across the UK. The fun...
Continue Reading →
News

AstraZeneca forges licensing agreement with Redx Pharma

AstraZeneca has signed a licensing deal with UK-based biotech company Redx Pharma for its fibrotic disease candidate RXC006. RXC006 is a porcupine inhibitor which ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026